Table of Contents
- Definition of Erysipelas and Molluscum Contagiosum
- Epidemiology of Erysipelas and Molluscum Contagiosum
- Etiology of Erysipelas and Molluscum Contagiosum
- Pathophysiology of Erysipelas and Molluscum Contagiosum
- Clinical Presentation of Erysipelas and Molluscum Contagiosum
- Diagnostic Workup for Erysipelas and Molluscum Contagiosum
- Differential Diagnosis of erysipelas
- Treatment of Erysipelas and Molluscum Contagiosum
Definition of Erysipelas and Molluscum Contagiosum
Erysipelas is a superficial skin infection that affects the dermis in addition to the superficial cutaneous lymphatics. The condition is caused by bacterial agents.
Molluscum Contagiosum is defined as a viral skin infection, resulting in a mild skin rash. The disease that only affects humans; it is generally mild and clears within 12 – 18 months without treatment. Molluscum Contagiosum causes multiple raised dome-shaped pink skin lesions that are umbilicated. The virus belongs to the Poxviridae family.
Epidemiology of Erysipelas and Molluscum Contagiosum
Erysipelas incidence has decreased since the introduction of antibiotics. In the past, most cases of erysipelas occurred on the face. Today, 80% of cases occur in the lower legs.
Possible risk factors for erysipelas include poor hygiene, poor sanitation, and history of lymphedema. The peak incidence of erysipelas is in patients older than 60 years. History of recent mastectomy, pelvic surgery, or bypass grafting increases the risk of erysipelas, most likely because of the associated risk of lymphedema.
Molluscum Contagiosum is one of the most common skin infections in the United States. Its prevalence is higher in patients with HIV, especially if the CD4 count is lower than 100 cells/microliter. Approximately 30% of Molluscum Contagiosum skin infection cases occur in AIDS patients.
Molluscum Contagiosum infection rates are higher among whites than other races, and it is more prevalent in males. The highest incidence of Molluscum Contagiosum infection is in children younger than 5 years of age. It is very rare in children younger than 1 year; in such cases, it is most likely because of maternally transmitted antibodies against the virus.
Etiology of Erysipelas and Molluscum Contagiosum
The most commonly implicated organism in erysipelas is streptococci. Group A streptococci are associated with most cases of facial erysipelas, while non-group A streptococci are associated with limb erysipelas. Newborns may also develop erysipelas due to group B streptococci.
Risk factors for developing erysipelas :
- People with lymphedema
- Nephrotic syndrome
- Arteriovenous insufficiency,
- Compromised body immunity
- Paretic limbs
Molluscum Contagiosum skin infection is caused by exposure to infected people. The virus can be inoculated from other people or from the same patient, known as auto-inoculation. Most cases have a history of recent skin trauma, such as shaving, because the virus is more likely to invade damaged skin rather than intact skin. Molluscum Contagiosum can also be transmitted sexually; hence, it can be considered a sexually transmitted disease in adults.
Three different viruses are thought to be responsible for Molluscum Contagiosum disease: Orthopoxvirus, Parapoxvirus, and unclassified Poxviridae viruses.
Pathophysiology of Erysipelas and Molluscum Contagiosum
Once streptococci enter damaged skin, the infection quickly invades the lymphatic vessels in the skin’s superficial layers, especially if the patient has lymphedema. When the bacteria start spreading in the lymphatic vessels, the skin overlying the infected area develops streaking. Swelling due to regional lymphadenopathy may be visible.
Molluscum Contagiosum viruses enter the cytoplasm of the epithelial cells, where they replicate. The infected cells enlarge in size and develop cytoplasmic inclusions. The virus can only replicate in the epidermis and is thought to affect humans exclusively. While the virus initially resides in the basal cell layer, viral replication and DNA synthesis occur after the virus enters the spindle and granular layers of the epidermis (this process takes about 7 weeks).
Viral replication and infection of the epidermis cause epithelial cell proliferation and lobulated epidermal growth. Additionally, fibrous septa between the epidermal growths occur, which eventually leads to the characteristic skin lesions associated with the virus. The virus does not develop latency; it evades the immune system by tricking it with viral-specific proteins.
Clinical Presentation of Erysipelas and Molluscum Contagiosum
Recent history of minor skin trauma can be noted in a few cases of erysipelas, but most cases happen with no preceding event. Here are some of the common prodromal systemic symptoms that patients often experience before the onset of skin infection:
- High fever
- Area of the skin that is tender to palpation
- Burning sensation
- Muscle pain and headaches
Previous medical history of diabetes, hypertension, and lymphedema are usually present.
Patients infected with Molluscum Contagiosum are usually asymptomatic. If patients develop any symptoms, they usually complain of recent onset of rounded dome-shaped skin lesions that can be multiple or single. These lesions are tender and painful. Fever, nausea, and fatigue are unusual.
Patients with certain skin conditions, such as eczema or psoriasis, are more likely to experience a viral infection spread. Scratching the skin lesions triggers auto-inoculation, and new lesions can form in the scratched areas. Multiple lesions can last up to three years, while single lesions usually resolve within two months. Recent history of contact with an infected individual might be elicited in a number of cases.
People with a history of HIV infection are at an increased risk of severe widespread erysipelas and Molluscum Contagiosum infections.
Diagnostic Workup for Erysipelas and Molluscum Contagiosum
Erysipelas is a clinical diagnosis and laboratory investigations are not needed. If blood testing is performed, patients can have leukocytosis, elevated erythrocyte sedimentation rate, and increased C-reactive protein levels in the blood.
Patients with severe joint pain might have septic arthritis or osteomyelitis. In these patients, magnetic resonance imaging and bone scintigraphy can be helpful. Blood and skin cultures can confirm the presence of bacterial infection but are usually negative; therefore, they are not recommended.
Similarly, Molluscum Contagiosum is also a clinical diagnosis. The skin lesions of Molluscum Contagiosum are very characteristic and are usually enough for the diagnosis. If a biopsy is performed, intracytoplasmic inclusion bodies can be seen on histologic examination.
Compression of the lesions can reveal a pasty core which, if stained properly, is usually abundant with the virus particles. Serum specific antibodies against Molluscum Contagiosum viruses are not clinically indicated, but they are available for research indications.
Polymerase chain reaction testing is available for quick and accurate confirmation of the presence of the virus in the skin lesions. Viral cultures do not have a role in Molluscum Contagiosum because routine cultures are not known to grow the virus. Adults with Molluscum Contagiosum are at risk of other sexually transmitted diseases and should be examined and offered the appropriate diagnostic workup to rule them out.
Differential Diagnosis of erysipelas
Erysipelas is a type of soft-tissue infection and should be differentiated from cellulitis, a similar dermatological condition.
|Acute infection of the dermis & deep subcutaneous tissue||Acute superficial infection of the dermis & upper subcutaneous tissue.|
Necrotic changes in deeper tissues are NOT seen.
Treatment of Erysipelas and Molluscum Contagiosum
Erysipelas treatment consists of two main components – prompt antibiotic administration and symptomatic treatment. Symptomatic treatment for fever and headache, adequate hydration, cold compresses of the affected lower limb, and elevating the affected limb will prevent the spread of the infection.
Penicillin administration, orally or intramuscularly, is the antibiotic of choice for treating erysipelas. Patients with penicillin allergies can be prescribed a first-generation cephalosporin. Clindamycin is a second-line antibiotic because some group B streptococci might be resistant. Roxithromycin and pristinamycin are two recently approved drugs for treating erysipelas; they are superior to penicillin and have fewer side effects.
Treatment options for Molluscum Contagiosum include no action, direct lesion trauma, antiviral therapy, and immune response stimulation. Children and healthy individuals should be assured that the lesions will eventually disappear and should be advised to ignore them.
Those who refuse this approach can benefit from minor direct lesion trauma. Cryotherapy, with liquid nitrogen, and curettage are the most commonly used forms of direct lesion trauma. They are effective but can be painful and uncomfortable for a child.
Imiquimod is a drug that activates the immune response against Molluscum Contagiosum. Despite its efficacy, it is too expensive to be considered for first-line therapy in healthy individuals.
Immunocompromised patients with Molluscum Contagiosum are at risk of severe and extensive infections; therefore, ritonavir and cidofovir should be administered intravenously. These antiviral drugs are proven effective in the treatment of extensive Molluscum Contagiosum disease in AIDS patients.